Taro Pharmaceutical Industries Stock In The News

TARO Stock  USD 42.34  0.08  0.19%   
The tone or emotional content of news articles related to Taro Pharmaceutical can affect its prices. Positive news sentiment can lead to an increase in demand for Taro Pharmaceutical's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Taro Pharmaceutical's news coverage and content from conventional and social sources shows investors' bearish mood towards Taro Pharmaceutical Industries. The specific impact of Taro Pharmaceutical news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Taro Pharmaceutical's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Taro Pharmaceutical headlines in addition to utilizing other, more conventional financial analysis modules. Check out Taro Pharmaceutical Backtesting and Taro Pharmaceutical Hype Analysis.

Taro Pharmaceutical Today Top News and Investor Outlook

Yahoo News
Chemical Linked to Cancer Found in Acne Creams Including Proactiv, Clearasil
https://finance.yahoo.com/news/chemical-linked-cancer-found-acne-143825624.html
 Neutral
Yahoo News
Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro
https://finance.yahoo.com/news/krensavage-asset-management-remains-opposed-120000991.html
 Bullish
Yahoo News
Taro Provides Results for December 31, 2023
https://finance.yahoo.com/news/taro-provides-results-december-31-220600207.html
 Bullish
Yahoo News
India's Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 million
https://sg.finance.yahoo.com/news/indias-sun-pharma-buy-remaining-232534907.html
 Bullish
Yahoo News
Taro Announces Merger Agreement with Sun Pharma
https://finance.yahoo.com/news/taro-announces-merger-agreement-sun-213000607.html
 Bullish
Yahoo News
Taro Announces Merger Agreement with Sun Pharma
https://finance.yahoo.com/news/taro-announces-merger-agreement-sun-213000500.html
 Bullish
Yahoo News
Amicus (FOLD) Banks on Galafold, Overdependence a Concern
https://finance.yahoo.com/news/amicus-fold-banks-galafold-overdependence-144800159.html
 Bullish
Yahoo News
Iovance (IOVA) Falls After Clinical Update on Lung Cancer Drug
https://finance.yahoo.com/news/iovance-iova-falls-clinical-lung-161300621.html
 Bullish
Yahoo News
Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate
https://finance.yahoo.com/news/senti-bio-snti-rises-fda-163200480.html
 Bullish
Yahoo News
Cidara (CDTX) Up on EC Nod for Rezzayo in Invasive Candidiasis
https://finance.yahoo.com/news/cidara-cdtx-ec-nod-rezzayo-155100953.html
 Bullish

Taro Pharmaceutical Industries Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Taro and other traded companies coverage. We help investors stay connected with Taro headlines for the 29th of March to make an informed investment decision based on correlating the impacts of news items on Taro Stock performance. Please note that trading solely based on the Taro Pharmaceutical Industries hype is not for everyone as timely availability and quick action are needed to avoid losses.
Taro Pharmaceutical's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Taro Pharmaceutical Industries investors visualize upcoming and past events in order to time the market based on Taro Pharmaceutical Industries noise-free hype analysis.
Taro Pharmaceutical stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Taro earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Taro Pharmaceutical that are available to investors today. That information is available publicly through Taro media outlets and privately through word of mouth or via Taro internal channels. However, regardless of the origin, that massive amount of Taro data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Taro Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Taro Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Taro Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Taro Pharmaceutical alpha.

Taro Largest EPS Surprises

Earnings surprises can significantly impact Taro Pharmaceutical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2001-04-30
2001-03-310.10.110.0110 
1994-08-02
1994-06-300.040.050.0125 
1995-10-26
1995-09-300.040.060.0250 
1995-02-23
1994-12-310.040.060.0250 
1994-11-01
1994-09-300.060.04-0.0233 
1994-05-11
1994-03-310.010.030.02200 
View All Earnings Estimates

Taro Pharmaceutical Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Taro Pharmaceutical Stock. Current markets are strongly bullish. About 72% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
28th of March 2024
Taro Pharmaceuticals U.S.A., Inc. Expands OTC Portfolio for Children with the Introduction...
at finance.yahoo.com 
news
21st of March 2024
Doctors Recommend Chilling Acne Creams Before Use To Reduce Cancer Risk
at ndtv.com 
Yahoo News
6th of March 2024
Chemical Linked to Cancer Found in Acne Creams Including Proactiv, Clearasil
at finance.yahoo.com 
Google News at Macroaxis
5th of March 2024
Pivots Trading Plans and Risk Controls - Stock Traders Daily.com
at news.google.com 
news
26th of February 2024
StockNews.com Begins Coverage on Taro Pharmaceutical Industries
at thelincolnianonline.com 
businesswire News
7th of February 2024
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick ...
at businesswire.com 
Google News at Macroaxis
29th of January 2024
Sun Pharmas Stock Surges 4 percent as Taro Pharma Reports Strong Q3 Performance - Indiainf...
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Taro Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Taro Pharmaceutical's short interest history, or implied volatility extrapolated from Taro Pharmaceutical options trading.
When determining whether Taro Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Taro Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Taro Pharmaceutical Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Taro Pharmaceutical Industries Stock:

Complementary Tools for Taro Stock analysis

When running Taro Pharmaceutical's price analysis, check to measure Taro Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taro Pharmaceutical is operating at the current time. Most of Taro Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Taro Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taro Pharmaceutical's price. Additionally, you may evaluate how the addition of Taro Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is Taro Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taro Pharmaceutical. If investors know Taro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taro Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.782
Earnings Share
1.22
Revenue Per Share
16.252
Quarterly Revenue Growth
0.129
Return On Assets
0.0103
The market value of Taro Pharmaceutical is measured differently than its book value, which is the value of Taro that is recorded on the company's balance sheet. Investors also form their own opinion of Taro Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Taro Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taro Pharmaceutical's market value can be influenced by many factors that don't directly affect Taro Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taro Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taro Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taro Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.